In Vitro Pharmacodynamic Parameters of Sordarin Derivatives in Comparison with Those of Marketed Compounds against <i>Pneumocystis carinii</i> Isolated from Rats
Pablo Avilés(GlaxoSmithKline (Spain)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), L. Dujardin(Institut Pasteur de Lille), Esperanza Herreros(GlaxoSmithKline (Spain)), Antonio Martı́nez(Hospital Universitario de Móstoles), Eduardo Dei‐Cas(Inserm), El Moukhtar Aliouat(Inserm)
Cited by 35
Related Papers
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
|Proceedings of the National Academy of Sciences|2013|519
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes
|Antimicrobial Agents and Chemotherapy|2009|189
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|PLoS ONE|2008|164
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
|Journal of Medicinal Chemistry|2008|139